Research Topic · Peer-Reviewed

Malignancy Diagnosis

Malignancy diagnosis is the process of identifying and characterising cancerous disease, distinguishing malignant tumours from benign lesions and determining their type, origin, and extent to guide treatment and prognosis. It integrates clinical evaluation with laboratory, imaging, and pathological methods. Histopat…

Curated from this journal's research 📚 7 peer-reviewed articles cited Cited 33× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Malignancy diagnosis is the process of identifying and characterising cancerous disease, distinguishing malignant tumours from benign lesions and determining their type, origin, and extent to guide treatment and prognosis. It integrates clinical evaluation with laboratory, imaging, and pathological methods. Histopathology and cytology, including biopsy and fine-needle aspiration, remain central, allowing direct examination of tissue and cells to confirm malignancy and classify tumours, while immunohistochemical and molecular markers refine subtype and origin. Imaging modalities such as ultrasonography, computed tomography, and functional studies assess tumour location, structure, and spread, and laboratory measures, including biomarkers and enzyme levels, can support detection and monitoring. Analytical and elemental techniques, such as trace-element profiling of tissue, have been explored as adjuncts for distinguishing malignant from benign alterations in certain organs. Accurate diagnosis depends on correlating these findings, since individual tests vary in sensitivity and specificity and malignancies can present in atypical or unexpected sites. In haematological and oncological practice, diagnosis also encompasses the evaluation of lymphoid and other lesions whose behaviour may be uncertain, requiring careful interpretation of suspicious or borderline results. Establishing a definitive diagnosis, with tumour grade, stage, and biological characteristics, is the foundation for therapeutic decisions, enabling targeted, timely, and appropriate management and informing the likely course of disease.

Research published in this journal

7 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 7 articles above have been cited 33 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Malignancy Diagnosis, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.